UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 小児に対する腎移植における免疫抑制 immunosuppression in renal transplantation in children
2. 成人の腎移植における免疫抑制誘導療法 induction immunosuppressive therapy in renal transplantation in adults
3. 再生不良性貧血：予後および治療 aplastic anemia prognosis and treatment
4. 成人における後天性赤芽球癆 acquired pure red cell aplasia in the adult
5. 急性腎同種移植片拒絶反応：治療 acute renal allograft rejection treatment

English Journal

A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.

Reid G, Huprikar S, Patel G, Razonable RR, Mossad S, Levi M, Gregg K, Shoham S, Humar A, Adams W, Kumar D.SourceDivision of Infectious Diseases, Loyola University Medical Center, Maywood, Illinois, USA.
Transplant infectious disease : an official journal of the Transplantation Society.Transpl Infect Dis.2013 Jul 25. doi: 10.1111/tid.12116. [Epub ahead of print]
BACKGROUND: Hematopoietic stem cell transplant (HSCT) recipients have increased morbidity from respiratory viral infections. Pandemic influenza A - A(H1N1)/pdm09 - in 2009-2010 was associated with increased severity of illness in patients with underlying co-morbidities including HSCT, but the factor
PMID 23890293

First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.

Peinemann F, Bartel C, Grouven U.SourceChildren's Hospital, University of Cologne, Kerpener Str. 62, Cologne, NW, Germany, 50937.
The Cochrane database of systematic reviews.Cochrane Database Syst Rev.2013 Jul 23;7:CD006407. [Epub ahead of print]
BACKGROUND: Acquired severe aplastic anemia is a rare and potentially fatal disease, which is characterized by hypocellular bone marrow and pancytopenia. The major signs and symptoms are severe infections, bleeding, and exhaustion. First-line allogeneic hematopoietic stem cell transplantation (HSCT)
PMID 23881658

Modelling cost effectiveness of horse antithymocyte globulin for treating severe aplastic anaemia in Germany.

Heublein S, Wehner F, Höchsmann B, Hochhaus A, Hartmann M, La Rosée P.SourceCenter for Sepsis Control and Care, Universitätsklinikum Jena, Jena, Germany. steffen.heublein@med.uni-jena.de
Annals of hematology.Ann Hematol.2013 Jun;92(6):825-30. doi: 10.1007/s00277-013-1688-2. Epub 2013 Feb 13.
Acquired severe aplastic anaemia (AA) is a serious condition caused by immune-triggered bone marrow failure. For patients not eligible for bone marrow transplantation, treatment of choice is immunosuppression by a combined treatment with antithymocyte globulin (ATG) and cyclosporine. The debate on t
PMID 23404582

Acute promyelocytic leukemia presenting initially with pancytopenia and severe hypocellular marrow which was successfully treated with all-trans retinoic acid and chemotherapy